Actuate Therapeutics raises ~$4.7M in private placement of common stock and warrants

ACTUATE THERAPEUTICS, INC.

Gross proceeds of approx. $4.7M from sale of 666,497 shares at $7.00/share and warrants to purchase 666,497 shares.
Warrants exercisable at $7.00 for 20 days after Milestone Date (FDA Breakthrough Therapy or registration determination for elraglusib).
Bios 2024 Co-Invest, LP (affiliated with Chairman Dr. Aaron G.L. Fletcher) purchasing 71,428 shares and warrants for ~$500K.
Closing expected on or before June 30, 2025; proceeds for working capital and general corporate purposes.
Registration rights agreement requires filing resale registration statement by August 9, 2025.

item 1.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.